**Optimizing Embryo Transfer Outcomes: Determinants for Improved Outcomes Using the Oocyte Donation Model**

Alan M. Martinez and Steven R. Lindheim *University of Cincinnati College of Medicine, Cincinnati, OH USA* 

## **1. Introduction**

148 Advances in Embryo Transfer

Spiewankiewicz, B., Stelmachow, J., Sawicki, W., Cendrowski, K., Wypych, P. & Swiderska,

Stamatellos, I., Apostolides, A., Stamatopoulos, P. & Bontis, J. (2008). Pregnancy rates after

*Archives of gynecology and obstetrics,* Vol.277, No.5, PP. 395-9, ISSN 0932-0067 Strickler, R. C., Christianson, C., Crane, J. P., Curato, A., Knight, A. B. & YANG, V. (1985).

Sundstrom, P., Wramsby, H., Persson, P. H. & Liedholm, P. (1984). Filled bladder simplifies

Thurin, A., Hausken, J., Hillensjo, T., Jablonowska, B., Pinborg, A., Strandell, A. & Bergh,

Turley, E. & Moore, D. (1984). Hyaluronate binding proteins also bind to fibronectin,

Valojerdi, M. R., Karimian, L., Yazdi, P. E., Gilani, M. A., Madani, T. & Baghestani, A. R.

Varasteh, N. N., Neuwirth, R. S., Levin, B. & Keltz, M. D. (1999). Pregnancy rates after

Visschers, B. A., Bots, R. S., Peeters, M. F., Mol, B. W. & Van Dessel, H. J. (2007). Removal of

Wisanto, A., Janssens, R., Deschacht, J., Camus, M., Devroey, P. & Van Steirteghem, A. C.

fertilization. *Human reproduction,* Vol.15, No.1, PP. 107-12, ISSN 0268-1161 Woolcott, R. & Stanger, J. (1997). Potentially important variables identified by transvaginal

Yanaihara, A., Yorimitsu, T., Motoyama, H., Iwasaki, S. & Kawamura, T. (2008). Location of

*gynecology,* Vol.94, No.2, PP. 168-71, ISSN 0029-7844

*online,* Vol.15, No.3, PP. 310-5, ISSN 1472-6483

Vol.90, No.1, PP. 180-2, ISSN 0015-0282

No.6, PP. 1434-8, ISSN 0015-0282

ISSN 0390-6663

PP. 54-61, ISSN 0015-0282

No.3, PP. 808-14, ISSN 0006-291X

506-7, ISSN 0306-5456

ISSN 0028-4793

12, ISSN 1058-0468

ISSN 0268-1161

macromolecule in a human embryo transfer medium. *Fertility and sterility*, Vol.79,

K. (2003). The effectiveness of hysteroscopic polypectomy in cases of female infertility. *Clinical and experimental obstetrics & gynecology,* Vol.30, No.1, PP. 23-5,

hysteroscopic polypectomy depending on the size or number of the polyps.

Ultrasound guidance for human embryo transfer. *Fertility and sterility,* Vol.43, No.1,

human embryo transfer. *British journal of obstetrics and gynaecology,* Vol.91, No.5, PP.

C. (2004). Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. *New England journal of medicine,* Vol.351, No.23, PP. 2392-402,

laminin and collagen. *Biochemical and biophysical research communications*, Vol.121,

(2006). Efficacy of a human embryo transfer medium: a prospective, randomized clinical trial study. *Journal of assisted reproduction and genetics*, Vol.23, No.5, PP. 207-

hysteroscopic polypectomy and myomectomy in infertile women. *Obstetrics and* 

cervical mucus: effect on pregnancy rates in IVF/ICSI. *Reproductive biomedicine* 

(1989). Performance of different embryo transfer catheters in a human in vitro fertilization program. *Fertility and sterility,* Vol.52, No.1, PP. 79-84, ISSN 0015-0282 Wood, E. G., Batzer, F. R., Go, K. J., Gutmann, J. N. & Corson, S. L. (2000). Ultrasound-

guided soft catheter embryo transfers will improve pregnancy rates in in-vitro

ultrasound-guided embryo transfer. *Human reproduction,* Vol.12, No.5, PP. 963-6,

endometrial polyp and pregnancy rate in infertility patients. *Fertility and sterility,*

The past decade has seen increased success rates with assisted reproductive technologies (ART), however, the overall pregnancy and implantation rates have remained relatively low. These low rates continue even though we now have improved stimulation protocols and laboratory techniques. Three areas that have gained specific attention include 1) identification of the optimal uterine environment; 2) extended embryo culture to the blastocyst stage; and 3) the embryo transfer (ET) technique, which has historically been viewed as an unimportant variable in the success of an ART treatment cycle. .

Discerning the impact on folliculogenesis and the endometrial level is difficult in conventional IVF cycles. Moreover, due to ethical quandaries, any study as complex as embryo and endometrial synchrony and receptivity is difficult to perform and thus reported studies in humans are more suggestive than conclusive. In contrast, the ovum donation model, which has been successfully used in treating infertility for over 25 years (Trounson et al., 1983), allows for the study of isolated parameters that may affect outcome by standardizing for embryo quality and endometrial receptivity and by optimizing the recruitment of high quality oocytes from the egg donor and eliminates the possible adverse effects of ovarian hyperstimulation (Acosta, 2000; Garcia, 1984; Oehninger, 2008).

In this chapter we will review the clinical variables that have gained increasing importance as prognostic determinants of implantation and variables to maximize ET outcomes of oocyte donation in an attempt to control for confounding variables seen in other clinical studies.

## **2. Endometrial thickness and pregnancy outcome in oocyte donation cycles**

To date, significant research has been done to directly assess uterine receptivity including histologic dating, measurement of endometrial sex steroid receptor concentrations using immuno-histochemical methods, assessing pinopod expression through scanning electron microscopy, and more recently the role of cytokines, growth factors, and integrin molecules have been studied (Castelbaum, 1997; Noci, 1995; Noyes, 1950; Paulson, 1997). Although these methods are important in furthering our understanding of uterine receptivity, they are not practical in actual ET cycles.

Optimizing Embryo Transfer Outcomes:

**outcomes in oocyte donation cycles** 

(women <36 years of age) (Papnikolaou et al., 2006).

Determinants for Improved Outcomes Using the Oocyte Donation Model 151

other confounding variables (Barker et al., 2009). Other studies using cleavage stage embryo transfer or a mixture of cleavage and blastocyst stage transfer therefore did not maximally control for the embryo factor (Abdalla, 1994; Check, 1993; Garcia-Velasco, 2003; Noyes, 2001; Remohi, 1997; Zenke, 2004). While this study was limited due to its retrospective design and limited power, it suggests that endometrial thickness in both the late-follicular and midluteal phase is not predictive of pregnancy outcomes. Moreover, thin endometrium and thickened endometrium (<7 mm, and >13 mm respectively), as well as pattern did not appear to be useful indicators of adverse endometrial receptivity (i.e. clinical outcomes).

In summary, research suggests that endometrial thickness may not be as helpful in predicting success as previously thought. Nonetheless, despite the many reports (some conflicting), the endometrial thickness and endometrial pattern are reassuring as a marker of endometrial receptivity and pregnancy outcomes. Further larger studies should confirm the present observations and what appears to be critical is the need for a uniform agreement by investigators to assess endometrial thickness and pattern in a more rigorous and

standardized fashion to gain further insight into their relative importance.

**3. Blastocyst embryo transfer is the primary determinant for improved** 

Another area that has drawn considerable attention is the blastocyst ET. Embryo culture has been extended from cleavage to the blastocyst stage transfer secondary to the introduction of sequential media allowing embryos to undergo cell compaction and genomic activation (Braude, 1988; Gardner, 1998). Two large randomized clinical trials and a recent Cochrane meta-analysis (Blake, 2007; Papnikolaou, 2005, 2006) suggest that blastocyst embryo transfers (ET) in good prognosis patients result in overall higher pregnancy and live-birth rates per ET, and has allowed for a reduction in the mean number of embryos transferred. Implantation rates have been reported to be as high as 60 to 65% per embryo transfer (Schoolcraft, 2001; Schillaci, 2002) with some in-vitro fertilization (IVF) programs advocating elective single ET in good prognosis patients

While our understanding of the developmental biology of pre-implantation stage embryos has substantially increased, overall implantation rates have remained relatively low with day-3 cleavage embryo transfers. Many IVF failures of seemingly normal embryos may occur as evidence suggests that extended blastocyst stage transfers result in significantly improved live-birth rates, including a Cochrane review by Blake et al (Blake et al., 2007).

The higher implantation and pregnancy rates appear to have a twofold explanation. First, it is principally thought to be the result of self selection and that only the most viable embryos develop into blastocysts, allowing these embryos to be transferred or cryopreserved (Schoolcraft, 2001; Schillaci, 2002). Studies suggest that a significant proportion of morphologically normal cleavage stage embryos are chromosomally abnormal and not destined to reach the blastocyst stage (Magli, 1998; Staessen, 2004), which appears to account for the high implantation failures seen in most cleavage stage ET cycles. This is despite the use of embryo classification systems including cell number and morphologic features of the fertilized oocyte, and cleavage stage embryos including pronuclei morphology, fragmentation, and blastomere uniformity (De Placido, 2002;

The measurement of endometrial thickness and its echogenic pattern, however, is an easy, non-invasive technique that has been used to assess endometrial receptivity prior to the embryo transfer. It is generally accepted that a thin endometrial stripe on transvaginal ultrasound is associated with a reduced embryo implantation potential (McWilliams, 2007; Rashidi, 2005; Schild, 2001; Zang, 2005; Zenke, 2004), while others have even reported an adverse effect of an increased endometrial thickness (Amir et al., 2007; Kovacs, 2003; Richter, 2007). The echogenic pattern of the endometrium has also been suggested to be a predictor of pregnancy outcome (Noyes, 2001; Sharara, 1999; Sher, 1991). Conversely, other studies have not shown sonographic assessment of the endometrium to be of any benefit in the characterization of uterine receptivity in IVF patients (Barufi, 2002; Dietterich, 2002; Garcia-Velasco, 2003; Sundstrom, 1998; Yuval, 1999). Nonetheless, despite these reports, the value of endometrial thickness and echogenic pattern are still undetermined as prognostic factors of implantation.

Oocyte donation cycles provide a unique model to eliminate confounding variables that typically occur when comparing groups of patients undergoing autologous IVF, where embryo quality and possible adverse effects of ovarian hyperstimulation on endometrial receptivity cannot be controlled. Endometrial proliferation strongly correlates with ovarian estradiol production, and therefore depends on ovarian function. Since age has an impact on ovarian function, embryo quality, estradiol production, endometrial thickness and pregnancy outcome often change in the same direction. In autologous cycles, poor endometrial development could be the sign of poor ovarian function (reduced estradiol production) and therefore is not independently responsible for lower implantation and pregnancy rates. Using an oocyte donation model, the endometrium can be developed by administration of exogenous sex steroids, with dose adjustment based on response (measured by serum estradiol level or endometrial thickness). Therefore endometrial proliferation becomes independent of ovarian function. In addition, oocyte donors are typically young women with normal ovarian reserve, thus embryos should characteristically be healthy with good implantation potential.

Few studies have evaluated the association between endometrial thickness pattern and pregnancy outcome using an oocyte donation model. Noyes et al., retrospectively analyzed 343 oocyte recipient cycles, in which endometrial thickness and pattern was evaluated on cycle day 12. They found that clinical pregnancy rate and live birth rate were significantly lower when endometrial thickness was less then 8mm than when endometrial thickness was greater than 9mm (Noyes et al., 2001). Zenke and Chetkowski reported in 41 recipient pairs with discordant outcomes that endometrial thickness less than 8 mm one week prior to oocyte retrieval was found in failed cycles (Zenke & Chetkowski, 2004).

In contrast, Remohi et al., performed a retrospective review of 465 oocyte donor cycles and found that there was no correlation between ultrasound appearance of the endometrium the day before embryo transfer and pregnancy rates (Remohi et al., 1997). Garcia-Velasco performed a matched pair analysis of 365 recipients with discordant outcome and found that endometrial thickness measured on cycle day 15 or 16 was not a significant finding (Garcia-Velasco et al., 2003). Barker et al. retrospectively examined endometrial thickness (in both the late follicular and mid-luteal phase) and treatment outcome in 132 oocyte donor IVF-ET cycles, using only blastocyst stage embryos which was thought to provide the best opportunity to assess the effect of these parameters on treatment outcome independent of

The measurement of endometrial thickness and its echogenic pattern, however, is an easy, non-invasive technique that has been used to assess endometrial receptivity prior to the embryo transfer. It is generally accepted that a thin endometrial stripe on transvaginal ultrasound is associated with a reduced embryo implantation potential (McWilliams, 2007; Rashidi, 2005; Schild, 2001; Zang, 2005; Zenke, 2004), while others have even reported an adverse effect of an increased endometrial thickness (Amir et al., 2007; Kovacs, 2003; Richter, 2007). The echogenic pattern of the endometrium has also been suggested to be a predictor of pregnancy outcome (Noyes, 2001; Sharara, 1999; Sher, 1991). Conversely, other studies have not shown sonographic assessment of the endometrium to be of any benefit in the characterization of uterine receptivity in IVF patients (Barufi, 2002; Dietterich, 2002; Garcia-Velasco, 2003; Sundstrom, 1998; Yuval, 1999). Nonetheless, despite these reports, the value of endometrial thickness and

echogenic pattern are still undetermined as prognostic factors of implantation.

be healthy with good implantation potential.

Oocyte donation cycles provide a unique model to eliminate confounding variables that typically occur when comparing groups of patients undergoing autologous IVF, where embryo quality and possible adverse effects of ovarian hyperstimulation on endometrial receptivity cannot be controlled. Endometrial proliferation strongly correlates with ovarian estradiol production, and therefore depends on ovarian function. Since age has an impact on ovarian function, embryo quality, estradiol production, endometrial thickness and pregnancy outcome often change in the same direction. In autologous cycles, poor endometrial development could be the sign of poor ovarian function (reduced estradiol production) and therefore is not independently responsible for lower implantation and pregnancy rates. Using an oocyte donation model, the endometrium can be developed by administration of exogenous sex steroids, with dose adjustment based on response (measured by serum estradiol level or endometrial thickness). Therefore endometrial proliferation becomes independent of ovarian function. In addition, oocyte donors are typically young women with normal ovarian reserve, thus embryos should characteristically

Few studies have evaluated the association between endometrial thickness pattern and pregnancy outcome using an oocyte donation model. Noyes et al., retrospectively analyzed 343 oocyte recipient cycles, in which endometrial thickness and pattern was evaluated on cycle day 12. They found that clinical pregnancy rate and live birth rate were significantly lower when endometrial thickness was less then 8mm than when endometrial thickness was greater than 9mm (Noyes et al., 2001). Zenke and Chetkowski reported in 41 recipient pairs with discordant outcomes that endometrial thickness less than 8 mm one week prior to

In contrast, Remohi et al., performed a retrospective review of 465 oocyte donor cycles and found that there was no correlation between ultrasound appearance of the endometrium the day before embryo transfer and pregnancy rates (Remohi et al., 1997). Garcia-Velasco performed a matched pair analysis of 365 recipients with discordant outcome and found that endometrial thickness measured on cycle day 15 or 16 was not a significant finding (Garcia-Velasco et al., 2003). Barker et al. retrospectively examined endometrial thickness (in both the late follicular and mid-luteal phase) and treatment outcome in 132 oocyte donor IVF-ET cycles, using only blastocyst stage embryos which was thought to provide the best opportunity to assess the effect of these parameters on treatment outcome independent of

oocyte retrieval was found in failed cycles (Zenke & Chetkowski, 2004).

other confounding variables (Barker et al., 2009). Other studies using cleavage stage embryo transfer or a mixture of cleavage and blastocyst stage transfer therefore did not maximally control for the embryo factor (Abdalla, 1994; Check, 1993; Garcia-Velasco, 2003; Noyes, 2001; Remohi, 1997; Zenke, 2004). While this study was limited due to its retrospective design and limited power, it suggests that endometrial thickness in both the late-follicular and midluteal phase is not predictive of pregnancy outcomes. Moreover, thin endometrium and thickened endometrium (<7 mm, and >13 mm respectively), as well as pattern did not appear to be useful indicators of adverse endometrial receptivity (i.e. clinical outcomes).

In summary, research suggests that endometrial thickness may not be as helpful in predicting success as previously thought. Nonetheless, despite the many reports (some conflicting), the endometrial thickness and endometrial pattern are reassuring as a marker of endometrial receptivity and pregnancy outcomes. Further larger studies should confirm the present observations and what appears to be critical is the need for a uniform agreement by investigators to assess endometrial thickness and pattern in a more rigorous and standardized fashion to gain further insight into their relative importance.

## **3. Blastocyst embryo transfer is the primary determinant for improved outcomes in oocyte donation cycles**

Another area that has drawn considerable attention is the blastocyst ET. Embryo culture has been extended from cleavage to the blastocyst stage transfer secondary to the introduction of sequential media allowing embryos to undergo cell compaction and genomic activation (Braude, 1988; Gardner, 1998). Two large randomized clinical trials and a recent Cochrane meta-analysis (Blake, 2007; Papnikolaou, 2005, 2006) suggest that blastocyst embryo transfers (ET) in good prognosis patients result in overall higher pregnancy and live-birth rates per ET, and has allowed for a reduction in the mean number of embryos transferred. Implantation rates have been reported to be as high as 60 to 65% per embryo transfer (Schoolcraft, 2001; Schillaci, 2002) with some in-vitro fertilization (IVF) programs advocating elective single ET in good prognosis patients (women <36 years of age) (Papnikolaou et al., 2006).

While our understanding of the developmental biology of pre-implantation stage embryos has substantially increased, overall implantation rates have remained relatively low with day-3 cleavage embryo transfers. Many IVF failures of seemingly normal embryos may occur as evidence suggests that extended blastocyst stage transfers result in significantly improved live-birth rates, including a Cochrane review by Blake et al (Blake et al., 2007).

The higher implantation and pregnancy rates appear to have a twofold explanation. First, it is principally thought to be the result of self selection and that only the most viable embryos develop into blastocysts, allowing these embryos to be transferred or cryopreserved (Schoolcraft, 2001; Schillaci, 2002). Studies suggest that a significant proportion of morphologically normal cleavage stage embryos are chromosomally abnormal and not destined to reach the blastocyst stage (Magli, 1998; Staessen, 2004), which appears to account for the high implantation failures seen in most cleavage stage ET cycles. This is despite the use of embryo classification systems including cell number and morphologic features of the fertilized oocyte, and cleavage stage embryos including pronuclei morphology, fragmentation, and blastomere uniformity (De Placido, 2002;

Optimizing Embryo Transfer Outcomes:

underestimated role in optimizing outcomes.

analysis (Drakeley et al., 2008).

**4. The ultrasound guided embryo transfer** 

Determinants for Improved Outcomes Using the Oocyte Donation Model 153

comparison of cleavage versus blastocyst stage embryo transfer in ART (including 9 randomized controlled studies with 1144 patients) provided evidence of a significant difference in live-birth rate per couple favoring blastocyst culture, with an odds ratio of 1.35 (Blake et al., 2010). Also, clinical pregnancy rate per couple in this review included 17

With respect to the ability to select HQ blastocysts, in cases where ≥6 good and high quality day-3 embryos were available, retrospective-blinded selection of one, two, and three embryo(s) was accurately selected more than 95% of the time and two embryos were correctly selected close to 70% of the time. Given the high likelihood of correctly identifying embryo(s) that would have been picked on day-6 and the increase in implantation rates from day-3 cleavage stage to day-6 blastocyst ET, the data suggest that the improved clinical pregnancy and implantation rates are not only the result of the extended embryo culture (thus allowing for the selection and transfer of the highest quality embryos), but also the more physiologic timing of the ET. Appropriate timing appears to play a significant and

Historically, ET has been viewed as an unimportant variable in the success of an ART treatment cycle (Stafford-Bell, 1999) and the technique has typically been performed in a blinded fashion without the use of ultrasound guidance. Recent studies have specifically addressed the technique of ET as being critical for optimizing outcome success, including factors such as the technique itself, the type of catheter, and the use of ultrasound (US) guidance (Abou-Setta, 2005, 2006; Bucket, 2003; Sallam & Sadek, 2003). The application of ultrasound guidance (two-dimensional transabdominal, as well as three-dimensional and four dimensional ultrasound-guided) to ET (Baba et al., 2000) has been described in more than 150 clinical trials including 20 randomized clinical trials and four meta-analyses including a Cochrane review (Abou-Setta, 2007; Brown, 2007; Buckett, 2003; Sallam & Sadek, 2003). These studies suggest that ultrasound-guided ET provides a benefit with respect to increases in clinical pregnancy and implantation rates, compared to the blind, "clinical touch" method and is a critical factor in optimizing pregnancy outcomes. However, other studies including a randomized controlled trial of 2295 embryo transfers by Drakeley et al failed to demonstrate any differences in ultrasound-guided ET compared to the blind, clinical touch which has not been included in any of the meta-

To date, only two studies have assessed US guided ET using the ovum donation model to eliminate confounding variables. In a retrospective study, Lindheim et al. assessed the impact of US guided easy or difficult ET on pregnancy rates, implantation rates, and multiple gestation rates in 137 cycles with and without US guidance using transvaginal or transabdominal US. US guidance significantly improved implantation and pregnancy rates in cycles with easy ET (29% vs. 18% and 63% vs. 36%, respectively p<0.05), without impacting multiple pregnancy rates. Similar trends for pregnancy, implantation, and multiple rates were seen for difficult ET, although statistical significance was not seen.

The only randomized clinical trail in patients undergoing oocyte donation was performed by Garcia-Velasco et al. They attempted to determine whether transabdominal ultrasound

studies, 2557 patients, with the odds ratio of 1.17 again favoring blastocyst culture.

Gamiz, 2003; Gianarolo, 2003; Hnida, 2004; Nagy, 2003; Nikas, 1999; Montag, 2001; Rienzi, 2005; Van Royen, 1999; Ziebe, 1997).

The second factor appears to be related to the contribution of the uterine environment, where endometrial receptivity occurs within a short window of <48 hours and is precisely timed with exposure to progesterone secretion (Nikas, 1999; Valbuena, 2001). However, unlike in-vivo embryos that normally travel through the fallopian tube and do not reach the uterus before the morula stage (four days post-ovulation), in-vitro cultured embryos that are transferred to the uterine cavity at the cleavage stage may be subjected to stress that normally would not occur. Some have argued that this environmental milieu and possible higher uterine contractility during cleavage stage ET results in expulsion of earlier transferred embryos and may account for the exceedingly high implantation failures seen in most IVF programs (Croxatto, 1972; Fanchin, 2001; Valbuena, 2001).

It is apparent that the uterine environment remains a critical component of embryo implantation. A variety of factors from both the blastocyst and endometrium appear to be critical to implantation including apposition, attachment, and invasion during a defined window, however, the blastocyst-endometrial interaction remains the least explored embryonic event (Garcia et al.,) and its role in implantation is not completely understood.

Clearly due to ethical quandaries, any study as complex as embryo and endometrial synchrony and receptivity is difficult to perform, and thus more suggestive than conclusive. Shapiro et al. demonstrated higher implantation and pregnancy rates occurring in day-5 compared to day-6 fresh autologous cycles, yet cryopreserved day-6 embryos in frozen transfer cycles outperformed day-6 fresh autologous cycles, while day-5 and day-6 cryopreserved embryos in frozen transfer cycles resulted in similar outcomes (Shapiro et al., 2008). These findings suggest the presence of different endometrial receptivities, and it is hypothesized that this may be due to better uterine synchrony. The egg donation model also shows that endometrial receptivity clearly plays a significant role, as evidenced by studies looking at discordant outcomes between autologous IVF patients who share half their oocytes to recipients. The recipient group was found to have both higher implantation and pregnancy rates, suggesting the importance of endometrial receptivity and the tenuous nature of the uterine environment(Check, 1999).

Using oocyte donation cycles (n=93), Porat et al. retrospectively evaluated the pregnancy and implantation rates in cleavage stage (day-3) versus blastocyst stage (day-6) embryo transfers (ET); and assessed 1) the predictive value of blastocyst formation rates based on objective cleavage cell stage and morphology grade and 2) evaluate the subjective ability (4 blinded reviewers) to predict formation of high quality blastocysts (fully expanded or hatching, with at least a fair inner cell mass and trophoectoderm, scored 4BB using Gardner's scoring system)in 546 normally fertilized embryos (n=546) that were cultured in sequential media (Porat et al., 2010). Cleavage stage cycles resulted in significantly lower pregnancy per ET, clinical pregnancy per ET, and implantation rates (47%; 40%; and 27% compared to blastocyst cleavage stage ET 82%; 73%; and 64%), despite significantly reduced numbers of embryos transferred compared to day-3 cleavage stage ET. In total, HQ blastocysts more likely resulted from HQ day-3 embryos (>6 cells, grades 1 and 1.5 [uniform cells, slight or no fragmentation]) (59%) compared to either good quality (43%) or fair-to poor quality day-3 embryos (55%), respectively. In a Cochrane review published in 2010, a

Gamiz, 2003; Gianarolo, 2003; Hnida, 2004; Nagy, 2003; Nikas, 1999; Montag, 2001; Rienzi,

The second factor appears to be related to the contribution of the uterine environment, where endometrial receptivity occurs within a short window of <48 hours and is precisely timed with exposure to progesterone secretion (Nikas, 1999; Valbuena, 2001). However, unlike in-vivo embryos that normally travel through the fallopian tube and do not reach the uterus before the morula stage (four days post-ovulation), in-vitro cultured embryos that are transferred to the uterine cavity at the cleavage stage may be subjected to stress that normally would not occur. Some have argued that this environmental milieu and possible higher uterine contractility during cleavage stage ET results in expulsion of earlier transferred embryos and may account for the exceedingly high implantation failures seen in

It is apparent that the uterine environment remains a critical component of embryo implantation. A variety of factors from both the blastocyst and endometrium appear to be critical to implantation including apposition, attachment, and invasion during a defined window, however, the blastocyst-endometrial interaction remains the least explored embryonic event (Garcia et al.,) and its role in implantation is not completely understood. Clearly due to ethical quandaries, any study as complex as embryo and endometrial synchrony and receptivity is difficult to perform, and thus more suggestive than conclusive. Shapiro et al. demonstrated higher implantation and pregnancy rates occurring in day-5 compared to day-6 fresh autologous cycles, yet cryopreserved day-6 embryos in frozen transfer cycles outperformed day-6 fresh autologous cycles, while day-5 and day-6 cryopreserved embryos in frozen transfer cycles resulted in similar outcomes (Shapiro et al., 2008). These findings suggest the presence of different endometrial receptivities, and it is hypothesized that this may be due to better uterine synchrony. The egg donation model also shows that endometrial receptivity clearly plays a significant role, as evidenced by studies looking at discordant outcomes between autologous IVF patients who share half their oocytes to recipients. The recipient group was found to have both higher implantation and pregnancy rates, suggesting the importance of endometrial receptivity and the tenuous

Using oocyte donation cycles (n=93), Porat et al. retrospectively evaluated the pregnancy and implantation rates in cleavage stage (day-3) versus blastocyst stage (day-6) embryo transfers (ET); and assessed 1) the predictive value of blastocyst formation rates based on objective cleavage cell stage and morphology grade and 2) evaluate the subjective ability (4 blinded reviewers) to predict formation of high quality blastocysts (fully expanded or hatching, with at least a fair inner cell mass and trophoectoderm, scored 4BB using Gardner's scoring system)in 546 normally fertilized embryos (n=546) that were cultured in sequential media (Porat et al., 2010). Cleavage stage cycles resulted in significantly lower pregnancy per ET, clinical pregnancy per ET, and implantation rates (47%; 40%; and 27% compared to blastocyst cleavage stage ET 82%; 73%; and 64%), despite significantly reduced numbers of embryos transferred compared to day-3 cleavage stage ET. In total, HQ blastocysts more likely resulted from HQ day-3 embryos (>6 cells, grades 1 and 1.5 [uniform cells, slight or no fragmentation]) (59%) compared to either good quality (43%) or fair-to poor quality day-3 embryos (55%), respectively. In a Cochrane review published in 2010, a

most IVF programs (Croxatto, 1972; Fanchin, 2001; Valbuena, 2001).

nature of the uterine environment(Check, 1999).

2005; Van Royen, 1999; Ziebe, 1997).

comparison of cleavage versus blastocyst stage embryo transfer in ART (including 9 randomized controlled studies with 1144 patients) provided evidence of a significant difference in live-birth rate per couple favoring blastocyst culture, with an odds ratio of 1.35 (Blake et al., 2010). Also, clinical pregnancy rate per couple in this review included 17 studies, 2557 patients, with the odds ratio of 1.17 again favoring blastocyst culture.

With respect to the ability to select HQ blastocysts, in cases where ≥6 good and high quality day-3 embryos were available, retrospective-blinded selection of one, two, and three embryo(s) was accurately selected more than 95% of the time and two embryos were correctly selected close to 70% of the time. Given the high likelihood of correctly identifying embryo(s) that would have been picked on day-6 and the increase in implantation rates from day-3 cleavage stage to day-6 blastocyst ET, the data suggest that the improved clinical pregnancy and implantation rates are not only the result of the extended embryo culture (thus allowing for the selection and transfer of the highest quality embryos), but also the more physiologic timing of the ET. Appropriate timing appears to play a significant and underestimated role in optimizing outcomes.

## **4. The ultrasound guided embryo transfer**

Historically, ET has been viewed as an unimportant variable in the success of an ART treatment cycle (Stafford-Bell, 1999) and the technique has typically been performed in a blinded fashion without the use of ultrasound guidance. Recent studies have specifically addressed the technique of ET as being critical for optimizing outcome success, including factors such as the technique itself, the type of catheter, and the use of ultrasound (US) guidance (Abou-Setta, 2005, 2006; Bucket, 2003; Sallam & Sadek, 2003). The application of ultrasound guidance (two-dimensional transabdominal, as well as three-dimensional and four dimensional ultrasound-guided) to ET (Baba et al., 2000) has been described in more than 150 clinical trials including 20 randomized clinical trials and four meta-analyses including a Cochrane review (Abou-Setta, 2007; Brown, 2007; Buckett, 2003; Sallam & Sadek, 2003). These studies suggest that ultrasound-guided ET provides a benefit with respect to increases in clinical pregnancy and implantation rates, compared to the blind, "clinical touch" method and is a critical factor in optimizing pregnancy outcomes. However, other studies including a randomized controlled trial of 2295 embryo transfers by Drakeley et al failed to demonstrate any differences in ultrasound-guided ET compared to the blind, clinical touch which has not been included in any of the metaanalysis (Drakeley et al., 2008).

To date, only two studies have assessed US guided ET using the ovum donation model to eliminate confounding variables. In a retrospective study, Lindheim et al. assessed the impact of US guided easy or difficult ET on pregnancy rates, implantation rates, and multiple gestation rates in 137 cycles with and without US guidance using transvaginal or transabdominal US. US guidance significantly improved implantation and pregnancy rates in cycles with easy ET (29% vs. 18% and 63% vs. 36%, respectively p<0.05), without impacting multiple pregnancy rates. Similar trends for pregnancy, implantation, and multiple rates were seen for difficult ET, although statistical significance was not seen.

The only randomized clinical trail in patients undergoing oocyte donation was performed by Garcia-Velasco et al. They attempted to determine whether transabdominal ultrasound

Optimizing Embryo Transfer Outcomes:

optimizing pregnancy outcomes.

pp.114-21, ISSN 0268-1161

No.4, (April 2000), pp.788–9, ISSN 0015-0282

(September 2000), pp.372-3, ISSN 1469-0705

8, ISSN 1472-6483

**6. References** 

Determinants for Improved Outcomes Using the Oocyte Donation Model 155

advantage due to the timing of transfer on day 5 or 6. Therefore, selection of high quality embryos remain paramount, and if possible delay of transfer to the blastocyst stage can allow for enhanced outcomes and an overall movement towards single embryo transfers. Lastly, US guided ET provides evidence for a standardized approach, minimizing operator variability in technique, and is likely an important asset in the embryo transfer process. There is overwhelming data suggesting that US guided ET are associated with improved outcomes compared to the blind, clinical touch method, and is another critical factor in

As reviewed in this chapter, the oocyte donation model has allowed for more precise control of many confounding variables seen in autologous IVF cycles, and should continue to play a vital role in our pursuit for optimizing outcomes. The variables discussed in this chapter, specifically the role of endometrial thickness and pattern, advent of blastocyst embryo transfer, and the assistance of embryo transfer with ultrasound guidance will no doubt

Abdalla, HI., Brooks, AA., Johnson, MR., Kirkland, A., Thomas, A., & Studd, JW. (1994).

Abou-Setta, AM. (2006). Firm embryo transfer catheters for assisted reproduction: a

Abou-Setta, AM., Mansour, RT., Al-Inany, HG., Aboulghar, MM., Aboulghar, MA., &

*Fertility and Sterility*, Vol.88, No.2, (August 2007), pp.333-41, ISSN 0015-0282 Acosta, AA., Elberger, L., Borghi, M., Calamera, JC., Chemes, H., Doncel, GF, Kliman, H.,

Amir, W., Micha, B., Ariel, H., Liat, LG., Jehoshua, D., & Adrian, S. (2007). Predicting factors

*Fertility and Sterility*, Vol.87, No.4, (April 2007), pp.799-804, ISSN 0015-0282 Baba, K., Ishihara, N., Saitoh, M., Taya, J., & Kinoshita, K. (2007). Three-dimensional

Barker, MA., Boehnlein, LM., Christianson, MS., Kovacs, P., & Lindheim, SR. (2009).

*Reproduction*, Vol.9, No.2, (Feburary 1994), pp.363-5, ISSN 0268-1161 Abou-Setta, AM., Al-Inany, HG., Mansour, RT., Serour, GI., & ABoulghar, MA. (2005). Soft

Endometrial thickness: a predictor of implantation in ovum recipients? *Human* 

versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis. *Human Reproduction*, Vol.20, No.11, (November 2005),

systematic review and meta analysis using direct and adjusted indirect comparisons. *Reproductive Biomedicine Online*, Vol.12, No.2, (February 2006), pp.191-

Serour, GI. (2007). Among women undergoing embryo transfer, is the probability of pregnancy and live birth improved with ultrasound guidance over clinical touch alone? A systemic review and meta-analysis of prospective randomized trials.

Lema, B., Lustig, L., & Papier, S. (2000). Endometrial dating and determination of the window of implantation in healthy fertile women. *Fertility and Sterility*, Vol.73,

for endometrial thickness during treatment with assisted reproductive technology.

ultrasound in embryo transfer. *Ultrasound In Obstetrics & Gynecology*, Vol.16, No.4,

Relationship of Follicular and Luteal Phase Endometrial Thickness plus Echogenic

continue to be evaluated as important determinants of IVF outcomes.

guidance during embryo transfer (ET) was a useful tool for increasing pregnancy rates. In this prospective, randomized, controlled trial that was powered to see a 15% increase chance of pregnancy, 374 patients undergoing oocyte donation were assigned to a transabdominal ultrasound-guided ET or the blind clinical touch.

Comparable pregnancy rates (60% ultrasound vs. 55% control); implantation rates (31% ultrasound vs. 26% control); miscarriage rates (11% ultrasound vs. 9% control); and multiple pregnancy rates (21% ultrasound vs. 23% control) were seen between groups. The authors concluded that that US guided ET did not provide any benefit in terms of pregnancy rate in oocyte recipients for whom ET was performed under direct transabdominal ultrasound visualization of the endometrial cavity.

Though these two studies are limited by their study design and adequate power, the overwhelming data suggest that US guided ET are associated with improved outcomes after IVF compared to the blind, clinical touch method and is a critical factor in optimizing pregnancy outcomes dispelling the historical notion that ET is an unimportant variable in the success of an ART treatment cycle (Brown, Mains & Van Voorhis, 2010). Moreover, it has been suggested that the ultrasound confirms the position of the tip of ET catheter and site of embryo deposition within the uterine cavity, increases the frequency of easy ET's, and avoids endometrial indentation. Most importantly, others argue that it allows for standardization of the transfer technique between physicians thus minimizing variation.

It is known that ease of the ET is strongly correlated to pregnancy outcome, and a difficult transfer, specifically with use of a more rigid catheter or the use of additional instrumentation may lower success rates. Soft catheters (Cook, Wallace) are preferred to the firm catheters (TDT, Frydman, Tomcat, Tefcat, Rocket) because of less cervical and endometrial trauma during the ET procedure, and easier transfer along the uterine axis (Mains, 2010; McDonald, 2002; Sallam, 2003). In comparisons between various soft catheters, pregnancy rates have not been shown to be significantly different (Saldeen et al., 2008).

## **5. Conclusion**

While improved stimulation protocols and laboratory techniques are given the most attention to optimizing outcomes in ART cycles, an increasing awareness to the importance ET has come into focus. Continued research in the area of the ET including endometrial receptivity (endometrial thickness as a surrogate marker), optimal embryo selection and replacement (using the blastocyst transfer), and ET technique (with ultrasound guidance) play significant factors in improving ART outcomes. The oocyte donation model provides a unique environment while eliminating many confounding variables seen in autologous cycles allowing the study of these important variables involved in IVF/ET success.

Current literature supports the notion that an endometrial thickness >7mm increases overall pregnancy outcomes Therefore, consideration of this variable should be noted in the treatment and counseling of patients undergoing IVF/ET. With respect to the timing of embryo transfer, there is clear evidence that blastocyst ET in good prognosis patients results in overall higher pregnancy and live-birth rates per ET. In addition, these enhanced rates have allowed for a reduction in the mean number of embryos transferred. Extending culture to the blastocyst stage, particularly in high quality cleavage-stage embryos, allows for selection of viable chromosomally normal embryos that may have an implantation advantage due to the timing of transfer on day 5 or 6. Therefore, selection of high quality embryos remain paramount, and if possible delay of transfer to the blastocyst stage can allow for enhanced outcomes and an overall movement towards single embryo transfers. Lastly, US guided ET provides evidence for a standardized approach, minimizing operator variability in technique, and is likely an important asset in the embryo transfer process. There is overwhelming data suggesting that US guided ET are associated with improved outcomes compared to the blind, clinical touch method, and is another critical factor in optimizing pregnancy outcomes.

As reviewed in this chapter, the oocyte donation model has allowed for more precise control of many confounding variables seen in autologous IVF cycles, and should continue to play a vital role in our pursuit for optimizing outcomes. The variables discussed in this chapter, specifically the role of endometrial thickness and pattern, advent of blastocyst embryo transfer, and the assistance of embryo transfer with ultrasound guidance will no doubt continue to be evaluated as important determinants of IVF outcomes.

## **6. References**

154 Advances in Embryo Transfer

guidance during embryo transfer (ET) was a useful tool for increasing pregnancy rates. In this prospective, randomized, controlled trial that was powered to see a 15% increase chance of pregnancy, 374 patients undergoing oocyte donation were assigned to a transabdominal

Comparable pregnancy rates (60% ultrasound vs. 55% control); implantation rates (31% ultrasound vs. 26% control); miscarriage rates (11% ultrasound vs. 9% control); and multiple pregnancy rates (21% ultrasound vs. 23% control) were seen between groups. The authors concluded that that US guided ET did not provide any benefit in terms of pregnancy rate in oocyte recipients for whom ET was performed under direct transabdominal ultrasound

Though these two studies are limited by their study design and adequate power, the overwhelming data suggest that US guided ET are associated with improved outcomes after IVF compared to the blind, clinical touch method and is a critical factor in optimizing pregnancy outcomes dispelling the historical notion that ET is an unimportant variable in the success of an ART treatment cycle (Brown, Mains & Van Voorhis, 2010). Moreover, it has been suggested that the ultrasound confirms the position of the tip of ET catheter and site of embryo deposition within the uterine cavity, increases the frequency of easy ET's, and avoids endometrial indentation. Most importantly, others argue that it allows for standardization of the transfer technique between physicians thus minimizing variation.

It is known that ease of the ET is strongly correlated to pregnancy outcome, and a difficult transfer, specifically with use of a more rigid catheter or the use of additional instrumentation may lower success rates. Soft catheters (Cook, Wallace) are preferred to the firm catheters (TDT, Frydman, Tomcat, Tefcat, Rocket) because of less cervical and endometrial trauma during the ET procedure, and easier transfer along the uterine axis (Mains, 2010; McDonald, 2002; Sallam, 2003). In comparisons between various soft catheters, pregnancy rates have not been shown to be significantly different (Saldeen et al., 2008).

While improved stimulation protocols and laboratory techniques are given the most attention to optimizing outcomes in ART cycles, an increasing awareness to the importance ET has come into focus. Continued research in the area of the ET including endometrial receptivity (endometrial thickness as a surrogate marker), optimal embryo selection and replacement (using the blastocyst transfer), and ET technique (with ultrasound guidance) play significant factors in improving ART outcomes. The oocyte donation model provides a unique environment while eliminating many confounding variables seen in autologous

Current literature supports the notion that an endometrial thickness >7mm increases overall pregnancy outcomes Therefore, consideration of this variable should be noted in the treatment and counseling of patients undergoing IVF/ET. With respect to the timing of embryo transfer, there is clear evidence that blastocyst ET in good prognosis patients results in overall higher pregnancy and live-birth rates per ET. In addition, these enhanced rates have allowed for a reduction in the mean number of embryos transferred. Extending culture to the blastocyst stage, particularly in high quality cleavage-stage embryos, allows for selection of viable chromosomally normal embryos that may have an implantation

cycles allowing the study of these important variables involved in IVF/ET success.

ultrasound-guided ET or the blind clinical touch.

visualization of the endometrial cavity.

**5. Conclusion** 


Optimizing Embryo Transfer Outcomes:

Determinants for Improved Outcomes Using the Oocyte Donation Model 157

Fanchin, R., Ayoubi, JM., Righini, C., Olivennes, F., Schonauer, LM., & Frydman, R. (2001).

Gamiz, P., Rubio, C., de los Santos, MJ., Mercader, A., Simon, C., Remohl, J., & Pellicer, A.

Garcia, JE., Acosta, AA., Hsiu, JG., & Jones, HW Jr. (1984). Advanced endometrial

García-Velasco, JA., Isaza, V., Martinez-Salazar, J., Landazábal, A., Requena, A., Remohí, J.,

Garcia-Velasco, JA., Isaza, V., Caligara, C., Pellicer, A., Remohí, J., & Simón, C. (2003).

Gardner, DK., Schoolcraft, WB., Wagley, L., Schlenker, T., Stevens, J., & Hesla, J. (1998). A

*Reproduction*, Vol.13, No.12, (December 1998), pp.3434-40, ISSN 0268-1161 Gianaroli, L., Magli, MC., Ferraretti, AP., Fortini, D., & Griecc, N. (2003). Pronuclear

Hnida, C., Engenheiro, E., & Ziebe, S. (2004). Computer-controlled, multilevel,

Kovacs, P., Matyas, S., Boda, K., & Kaali, SG. (2003). The effect of endometrial thickness on

Lindheim, SR., Cohen, MA., & Sauer, MV. (1999). Ultrasound guided embryo transfer

Magli, MC., Gianaroli, L., Munne, S., & Ferratetti, AP. (1998). Incidence of chromosomal

Mains, L., & Van Voorhis, BJ. (2010). Optimizing the technique of embryo transfer. *Fertility and Sterility*, Vol.93, No.3, (August 2010), pp.785-790, ISSN 0015-0282 McDonald JA, Norman RJ. A randomized controlled trial of a soft double lumen embryo

*Reproduction*, Vol.16, No.6, (June 2001), pp.1115-9, ISSN 0268-1161

Vol.18, No.11, (November 2003), pp.2413-19, ISSN 0268-1161

*Sterility*, Vol.80, No.1, (July 2003), pp.54-60, ISSN 0015-0282

No.1, (January 1984), pp.31–5, ISSN 0015-0282

(September 2002) , pp.534-9, ISSN 0015-0282

2004), pp.288-93, ISSN 0268-1161

41, ISSN 0268-1161

pp.281-4, ISSN 0020-7292

pp.297-301, ISSN 1573-7330

pregnancy rates. Hum Reprod 2002;17:1502–6

Uterine contractility decreases at the time of blastocyst transfers. *Human* 

(2003). The effect of pronuclear morphology on early development and chromosomal abnormalities in cleavage-stage embryos. *Human Reproduction*,

maturation after ovulation induction with human menopausal gonadotropin human chorionic gonadotropin for in vitro fertilization. *Fertility and Sterility*, Vol.41,

& Simón, C. (2002).Transabdominal ultrasound-guided embryo transfer does not increase pregnancy rates in oocyte recipients. *Fertility and Sterility*, Vol. 78, No.3,

Factors that determine discordant outcome from shared oocytes. *Fertility and* 

randomized trial of blastocyst culture and transfer in in-vitro fertilization. *Human* 

morphology and chromosomal abnormalities as scoring criteria for embryo slection. *Fertility and Sterility*, Vol.80, No.2, (August 2003), pp.341-9, ISSN 0015-0282

morphometric analysis of blastomere size as biomarker of fragmentation and multinuclearity in human embryos. *Human Reproduction*, Vol.19, No.2, (February

IVF/ICSI outcome. *Human Reproduction*, Vol.18, No.11, (November 2003), pp.2337-

significantly improves pregnancy rates in women undergoing oocyte donation. *International Journal of Gynaecology and Obstetrics,* Vol. 66, No.3, (September 1999),

abnormalities from a morphologically normal cohort of embryos in poor-prognosis patients. *Journal of Assisted Reproduction and Genetics*, Vol.15, No.5, (May 1998),

transfer catheter versus a firm single lumen catheter: significant improvements in

Pattern and Pregnancy Outcome in Oocyte Donation Cycles. *Journal of Assisted Reproduction and Genetics*, Vol.26, No.5, (May 2009), pp.243-9, ISSN 1573-7330


Blake, DA., Farquhar, CM., Johnson, N., & Proctor, M. (2007). Cleavage stage versus

*of Systematic Reviews*, Vol. 17, No.4, (October 2007), pp.1-79, ISSN 1469-493X Braude, P., Bolton, V., & Moore, S. (1988). Human gene expression first occurs between the

Brown, JA., Buckingham, K., Abou-Setta, A., & Buckett, W. (2007). Ultrasound versus

*Database of Systematic Reviews* , Vol.24, No.1, (January 2007), ISSN 1469-493X Buckett, WM. (2003). A meta-analysis of ultrasound-guided versus clinical touch embryo

Castelbaum, AJ., Ying, L., Somkuti, SG., Sun, J., Ilesanni, AO., & Lessey, BA. (1997).

Check, JH., Nowroozi, K., Choe, J., Lurie, D., & Dietterich, C. (1993). The effect of

Check, JH., Choe, JK., Kotsoff, D., Summers-Chase, D., & Wilson, C. (1999). Controlled

Croxatto, HB., Fuentealba, B., Diaz, S., Patene, L., &Tatum, HJ. (1972). A simple nonsurgical

(March 2002), pp.99-102, ISSN 1573-7330

0282

7197

pp.72-5, ISSN 0015-0282

No.6163, (March 1988), pp.459-61, ISSN 0028-0836

No.8, (September 1999), pp. 416-20, ISSN 1573-7330

Pattern and Pregnancy Outcome in Oocyte Donation Cycles. *Journal of Assisted Reproduction and Genetics*, Vol.26, No.5, (May 2009), pp.243-9, ISSN 1573-7330 Baruffi, RLR., Contart, P., Mauri, AL., Peterson, C., Felipe, V., Garbellini, E., & Franco, JG. Jr.

(2002). A uterine ultrasonographic scoring system as a method for the prognosis of embryo implantation. *Journal of Assisted Reproduction and Genetics*, Vol.19, No.3,

blastocyst stage embryo transfer in assisted conception (Review). *Cochrane Database* 

four and eight-cell stages of pre-implantation development. *Nature*, Vol.332,

'clinical touch' for catheter guidance during embryo transfer in women. *Cochrane* 

transfer. *Fertility and Sterility*, Vol.80, No.4, (October 2003), pp.1037-41, ISSN 0015-

Characterization of integrin expression in well differentiated endometrial a endometrial adenocarcinoma cell line (Ishikawa). *The Journal of Clinical Endocrinology and Metabolism*, Vol.82, No.1, (January 1997), pp.136-142. ISSN 1945-

endometrial thickness and echo pattern on in vitro fertilization outcome in donor oocyte-embryo transfer cycle. *Fertility and Sterility,* Vol.59, No.1, (January1993),

ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer. *Journal of Assisted Reproduction and Genetics,* Vol.16,

technique to obtain unimplanted eggs from human uteri. *American Journal of Obstetrics and Gynecology*, Vol.112, No.5, (March 1972), pp.662-8, ISSN 0002-9378 De Placido, G., Wilding, M., Strina, I., Alviggi, E., Alviggi, C., Mollo, A., Varicchio, MT.,

Tolino, A., Schiattarella, C., & Dale, B. (2002). High outcome predictability after IVF using a combined score for zygote and embryo morphology and growth rate. *Human Reproduction*, Vol.17, No.9, (September 2002), pp.2402-09, ISSN 0268-1161 Dietterich, C., Check, JH., Choe, JK., Nazari, A., & Lurie, D. (2002). Increased endometrial

thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer. *Fertility and Sterility*, Vol.77, No.4, (April 2002), pp.781-86, ISSN 0015-0282 Drakeley, AJ., Jorgensen, A., Sklavounos, J., Aust, T., Gazvani, R., Williamson, P., &

Kingsland, CR. (2005). A randomized controlled clinical trial of 2295 ultrasound.

*Human Reproduction*, Vol.23, No.5, (2008), pp.1101-06, ISSN 0268-1161


Optimizing Embryo Transfer Outcomes:

pp.2271-2276, ISSN 0268-1161

pp.1042-6, ISSN 0015-0282

0015-0282

(January 2007), pp.53-59, ISSN 0015-0282

*18th Annual Meeting of ESHRE, Vienna*, 2002, P-418.

Vol.89, No.1, (January 2008), pp.20-26, ISSN 0015-0282

No.10, (November 1999), pp.523-28, ISSN 1573-7330

(February 1991), pp.232-37, ISSN 0268-1161

0301-2115

6483

Determinants for Improved Outcomes Using the Oocyte Donation Model 159

Remohí, J., Ardiles, G., García-Velasco, JA., Gaitán, P., Simón, C., & Pellicer, A. (1997).

Rienzi, L., Ubaldi, F., Iacobelli, M., Romano, S., Minasi, MG., Ferrero, S., Sapienza, F., Baroni

Richter, KS., Bugge, KR., Bromer, JG., & Levy, MJ. (2007). Relationship between endometrial

Sallam HN, Agameya AF, Rahman AF, Ezzeldin F, Sallam AN. Impact of technical

Schild, RL., Knobloch, C., Dorn, C., Fimmers, R., van der Ven, H., & Hansmann, M. (2001).

Schillaci, R., Castelli, A., Vassiliadis, A., Venzia, R., Sciacca, GM., Perino, A., & Cittadini, E.

Schoolcraft, WB., & Gardner, DK. (2001). Blastocyst versus day 2 or 3 transfer. *Seminars in Reproductive Medicine,* Vol.19, No.3, (September 2001), pp.259-268, ISSN 1526-8004 Shapiro, BS., Daneshmand, ST., Garner, FC., Aguirre, M., & Ross, R. (2008). Contrasting

Sharara, FI., Lim, J., & McClamrock, HD. (1999). Endometrial pattern on the day of oocyte

Sher, G., Herbert, C., Maassarani, G., & Jacobs, MH. (1991). Assessment of the late

Staessen, C., Platteau, P., Van Assche, E., Michiels, A., Tournaye, H., Camus, M., Devroey,

*Gynecology, and Reproductive Biology*, Vol.120, No.2, (June 2005), pp.179-184, ISSN

Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. *Human Reproduction,* Vol.12, No.10, (October 1997),

,E., & Greco, E. (2005). Significance of morphological attributes of the early embryo. *Reproductive Biomedicine Online*, Vol.10, No.5, (May 2005), pp.669-681, ISSN 1472-

thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. *Fertility and Sterility*, Vol.87, No.1,

difficulties, choice of catheter, and the presence of blood on the success of embryo transfer: experience from a single provider. J Assist Reprod Genet 2003;20:135–42 Sallam, HN., & Sadek, SS. (2003). Ultrasound-guided embryo transfer: a meta-analysis of

randomized controlled trials. *Fertility and Sterility*, Vol.80, No.4, (October 2003),

Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow. *Fertility and Sterility*, Vol. 75, No.2, (February 2001), pp.361-66, ISSN

(2002). Blastocyst stage versus day 2 embryo transfer in IVF cycles. *Abstracts of the* 

patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. *Fertility and Sterility*,

retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. *Journal of Assisted Reproduction and Genetics*, Vol.16,

proliferative phase endometrium by ultrasonography in patients undergoing invitro fertilization and embryo transfer (IVF-ET). *Human Reproduction*, Vol.6, No.2,

P., Liebaers, I., & Van Steirteghem, A. (2004). Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in


McWilliams, GD., & Frattarelli, JL. (2007). Changes in measured endometrial thickness

Montag, M., & van der Ven, H. (2001). Evaluation of pronuclear morphology as the only

Nagy, ZP., Dozortsev, D., Diamond, M., Rienzi, L., Ubaldi, F., Adelmassih, R., & Greco, E.

Nikas, G., Develioglu, OH., Toner, JP., & Jones, HW. Jr. (1999). Endometrial pinopodes

Noci, I., Borri, P., Chieffi, O, Scarsselli, G., Biaglotti, R., Moncini, D., Paglierani, M., &

*Fertility and Sterility*, Vol.76, No.1, (July 2001), pp.92-97, ISSN 0015-0282 Noyes, RW., Hertig, AT., & Rock, J. (1950). Dating the endometrial biopsy. *Fertility and* 

Oehninger, S. (1950). Revealing the enigmas of implantation: what is the true impact of

Papnikolaou, EG., D'haeseleer, E., Verheyen, G., Van de Velde, H., Camus, M., Van

*Reproduction*, Vol.20, No.11, (November 2005), pp.3198-203, ISSN 0268-1161 Papnikolaou, EG., Camus, M., Kolibianakis, EM., Landuyt, LV., Van Steirteghem, A., &

Paulson, RJ., Sauer, MV., & Lobo, RA. (1997). Potential enhancement of endometrial

Porat, N., Boehnlein, LM., Barker, MA., Kovacs, P., & Lindheim, SR. (2010). Blastocyst

Rashidi, BH., Sadeghi, M., Jafarabadi, M., & Tehrani Nejad, ES. (2005). Relationships

pp.74-81, ISSN 0015-0282

30, 0015-0282

0015-0282

2006), pp.1139-46., ISSN 00284793

2010), pp.357-63, ISSN 1447-0756

2001), pp.2384-89, ISSN 0268-1161

No.1, (July 2003), pp.67-74, ISSN 0015-0282

Vol.14, No.3, (March 1999), pp.787-92, ISSN 0268-1161

*Sterility*, Vol.1, No.3, (March 1950), pp.1-3, ISSN 0015-0282

predict in vitro fertilization success. *Fertility and Sterility*, Vol.88, No.1, (July 2007),

selection criterion for further embryo culture and transfer: results of a prospective randomized multicentre study. Human *Reproduction*, Vol.16, No.11, (November

(2003). Pronuclear morphology evaluation with subsequent evaluation of embryo morphology significantly increases implantation rates. *Fertility and Sterility*, Vol.80,

indicate a shift in the window of receptivity in IVF cycles. *Human Reproduction*,

Taddei, G. (1995). Aging of the human endometrium: a basic morphological and immunohistochemical study. *European Journal of Obstetrics & Gynecology, and Reproductive Biology*, Vol.63, No.2, (December 1995), pp.181-85, ISSN 0301-2115 Noyes, N., Hampton, BS., Berkeley, A., Licciardi, F., Grifo, J., & Krey, L. (2001). Factors

useful in predicting the success of oocyte donation: a 3-year retrospective analysis.

ovarian hyperstimulation? *Fertility and Sterility*, Vol.89, No.1, (January 1950), pp27–

Steirteghem, A., Devroey, P., & Tournaye, H. (2005). Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage transfer when at least four embryos are available on day 3 of culture. A randomized prospective study. *Human* 

Devroey, P. (2006). In vitro fertilization with single blastocyst-stage versus cleavage-stage embryos. *New England Journal of Medicine*, Vol.354, No.11, (March

receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis. *Fertility and Sterility*, Vol.67, No.2, (February 1997), pp.321-25, ISSN

Embryo Transfer is the Primary Determinant for Improved Outcomes in Oocyte Donation Cycles. *Journal of Obstetrics and Gynaecology Research*, Vol.36, No.2, (April

between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern. *European Journal of Obstetrics,*  *Gynecology, and Reproductive Biology*, Vol.120, No.2, (June 2005), pp.179-184, ISSN 0301-2115


**11**

*Slovenia* 

**Importance of Blastocyst Morphology**

Prolonged cultivation of embryos to the blastocyst stage has become a routine practice in the human in vitro fertilization program (IVF) since 1999, when the first commercial sequential media were developed. The culture systems have been improved many times and today most of the blastocyst culture media enable the embryos to reach the blastocyst stage in more than 50% of cases (Gardner et al., 1998; Kovačič et al., 2004). The advantages of blastocyst culture are in the possibilities for selection of embryos that have an activated genome (Braude et al., 1988), higher predictive values for implantation on the basis of their morphological appearance as compared with earlier embryos (Gardner and Schoolcraft, 1999; Kovačič et al., 2004) and in a reduction in the number of transferred embryos without compromising pregnancy rate (Gardner et al., 2000a). Blastocyst is also a stage that is better synchronized with endometrial receptivity for its implantation (Croxatto et al., 1978; Gardner et al., 2000c). By replacement of embryos in the blastocyst stage, their exposure to hyperstimulated milieu and consequent endometrial contractions, which could be fatal for them, is significantly shortened (Lesny et al., 1998). Blastocysts also contain a larger number of cells than early stage embryos and should therefore have a better possibility of survival of

The first synthetic medium of only 9 components for mammalian embryos was developed 50 years ago. Since then, intensive research has continued to develop the optimum chemically defined media for human embryos (Summers and Biggers, 2003). In various parts of the female reproductive tract, a precise biochemical analysis of uterine and Fallopian tubal fluids was carried out and the metabolism of energy substrates has also been studied (Leese et al., 1993; Conagham et al., 1993; Houghton et al., 2002; Gardner et al., 2001). These investigations lead to the development of sequential media for prolonged cultivation of human embryos (Gardner and Lane, 1997). After that, the media have been modified several times by adding other macromolecules, which enhance embryo development and implantation, e.g. EDTA (Gardner et al., 2000b) and hyaluronan (Stojković et al., 2002)**.** Also, the toxicity of the medium occurring due to the degradation of amino acids was decreased by substituting the heat-sensitive glutamine for the more stable alanylglutamine (Lane et al., 2001). By using commercial blastocyst media in the human IVF

**1. Introduction** 

cryopreservation (Veeck, 2003).

**2. Blastocyst culture** 

**in Selection for Transfer**

Borut Kovačič and Veljko Vlaisavljević

*University Medical Centre Maribor* 

couples with advanced maternal age: a prospective randomized controlled trial. *Human Reproduction*, Vol.19, No.12, (December 2004), pp.2849-58, ISSN 0268-1161

